Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancerChelsea Jackson, David M. Berman, Vanessa Freitas Bratti et al.|The Journal of Pathology Clinical Research|2021Cited by 23
Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy ClassifiersCéline Hardy, Chelsea Jackson, Hamid Ghaedi et al.|Journal of Histochemistry & Cytochemistry|2022Cited by 17
Predictive and Prognostic Performance of IHC3 Immunohistochemistry-based Molecular Subtyping in Muscle-Invasive Bladder CancerCéline Hardy, D. M. Berman, L Chen et al.|Urologic Oncology Seminars and Original Investigations|2020Cited by 0
Abstract 616: Performance of IHC3-Uro immunohistechemistry-based molecular subtyping in muscle-invasive bladder cancerCéline Hardy, David M. Berman, Chelsea Jackson et al.|Clinical Research (Excluding Clinical Trials)|2021Cited by 0
Immunohistochemical assays for bladder cancer molecular subtyping: Optimizing parsimony and performance using Lund taxonomyCéline Hardy, Chelsea Jackson, Hamid Ghaedi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0